Dr. Martens plc
DOCS.L · LSE
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | £481,709 | – | £532,291 |
| - Cash | £95,700 | £155,900 | – | £94,900 |
| + Debt | £347,500 | £404,100 | – | £449,700 |
| Enterprise Value | – | £729,909 | – | £887,091 |
| Revenue | £322,000 | – | £463,000 | £324,600 |
| % Growth | – | – | 42.6% | – |
| Gross Profit | £175,700 | – | £304,000 | £207,700 |
| % Margin | 54.6% | – | 65.7% | 64% |
| EBITDA | £37,700 | – | £115,000 | -£4,500 |
| % Margin | 11.7% | – | 24.8% | -1.4% |
| Net Income | -£10,000 | – | £25,300 | -£20,800 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS Diluted | -0.01 | – | 0.026 | -0.022 |
| % Growth | – | – | 219.1% | – |
| Operating Cash Flow | -£16,100 | – | £142,500 | £35,300 |
| Capital Expenditures | -£4,200 | – | -£4,200 | -£4,200 |
| Free Cash Flow | -£20,300 | – | £138,300 | £31,100 |